The company, along with others, is pursuing a new paradigm for cramming more transistors on chips—building up.
Silver nanoparticles provide a more efficient way to cut and assemble DNA, improving recovery rates and boosting DNA joining ...
Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results